Page last updated: 2024-11-03

primaquine and Cytomegalovirus Infections

primaquine has been researched along with Cytomegalovirus Infections in 2 studies

Primaquine: An aminoquinoline that is given by mouth to produce a radical cure and prevent relapse of vivax and ovale malarias following treatment with a blood schizontocide. It has also been used to prevent transmission of falciparum malaria by those returning to areas where there is a potential for re-introduction of malaria. Adverse effects include anemias and GI disturbances. (From Martindale, The Extra Pharmacopeia, 30th ed, p404)
primaquine : An N-substituted diamine that is pentane-1,4-diamine substituted by a 6-methoxyquinolin-8-yl group at the N(4) position. It is a drug used in the treatment of malaria and Pneumocystis pneumonia.

Cytomegalovirus Infections: Infection with CYTOMEGALOVIRUS, characterized by enlarged cells bearing intranuclear inclusions. Infection may be in almost any organ, but the salivary glands are the most common site in children, as are the lungs in adults.

Research Excerpts

ExcerptRelevanceReference
"The primaquine group had lower 90-day mortality rate (45."1.72Prognostic factors and clinical efficacy of second-line treatments of Pneumocystis jirovecii pneumonia for non-HIV patients after first-line treatment failure. ( Cao, G; Liu, A; Liu, X; Sun, R; Yang, J; Zhu, H, 2022)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Liu, A1
Sun, R1
Cao, G1
Liu, X1
Zhu, H1
Yang, J1

Other Studies

2 other studies available for primaquine and Cytomegalovirus Infections

ArticleYear
Prognostic factors and clinical efficacy of second-line treatments of Pneumocystis jirovecii pneumonia for non-HIV patients after first-line treatment failure.
    BMC infectious diseases, 2022, Jun-14, Volume: 22, Issue:1

    Topics: Bacteremia; Clindamycin; Coinfection; Cytomegalovirus Infections; Humans; Pneumocystis carinii; Pneu

2022
Drugs for AIDS and associated infections.
    The Medical letter on drugs and therapeutics, 1995, Oct-13, Volume: 37, Issue:959

    Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Amphotericin B; Antifunga

1995